Edition:
United States

UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

472JPY
20 Jan 2017
Change (% chg)

¥8 (+1.72%)
Prev Close
¥464
Open
¥467
Day's High
¥477
Day's Low
¥462
Volume
674,300
Avg. Vol
385,485
52-wk High
¥2,755
52-wk Low
¥461

4585.T

Chart for 4585.T

About

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacture and sale of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal... (more)

Overall

Beta: 2.67
Market Cap(Mil.): ¥5,756.75
Shares Outstanding(Mil.): 12.20
Dividend: --
Yield (%): --

Financials

  4585.T Industry Sector
P/E (TTM): -- 44.85 30.38
EPS (TTM): -304.07 -- --
ROI: -54.05 -1.38 14.86
ROE: -1,229.42 -1.07 16.28

BRIEF-Astellas terminates agreement with UMN Pharma for cell culture based influenza vaccine programs

* Says co terminates agreement with UMN Pharma Inc , for the co-development and Astellas' exclusive commercialization of ASP7374 and ASP7373, the cell culture based influenza vaccine programs in Japan

Jan 10 2017

BRIEF-UMN Pharma announces exercise of options

* Says 150,000 units of its 20 series options were exercised to 150,000 shares of its common stock on Jan. 6

Jan 06 2017

BRIEF-UMN Pharma announces exercise of options

* Says 250,000 units of its 19th series options were exercised to 250,000 shares of its common stock on Aug. 24

Aug 25 2016

BRIEF-UMN Pharma announces exercise of options

* Says 200,000 units of its 19th series options were exercised to 200,000 shares of its common stock, comprised of 100,000 shares at exercise price 1,040 yen on Aug. 17 and 100,000 shares at exercise price 1,037 yen on Aug. 24

Aug 24 2016

Earnings vs. Estimates